Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status:
Terminated
Trial end date:
2020-06-10
Target enrollment:
Participant gender:
Summary
The main objectives of this study are:
- Determine the difference in change from baseline in Six Minute Walk Distance (6MWD) when
pulmonary rehabilitation (PR) is added to stable underlying nintedanib therapy in
patients with idiopathic pulmonary fibrosis (IPF)
- Determine the difference in change in Quality of Life (QoL) when pulmonary
rehabilitation (PR) is added to stable underlying nintedanib therapy in patients with
idiopathic pulmonary fibrosis (IPF)
- Determine if there is an enduring effect in 6MWD, QoL and lung function from pulmonary
rehabilitation (PR) when pulmonary rehabilitation (PR) is added to stable underlying
nintedanib therapy in patients with idiopathic pulmonary fibrosis (IPF)